BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20569272)

  • 1. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.
    Sumitomo M; Asakuma J; Yoshii H; Sato A; Horiguchi A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Sep; 17(9):776-82. PubMed ID: 20569272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment to Anterior perirectal fat tissue thickness closely associated with obesity strongly predicts recurrence after high-intensity focused ultrasound for prostate cancer.
    Hekal IA
    Int J Urol; 2010 Sep; 17(9):782-3. PubMed ID: 20727049
    [No Abstract]   [Full Text] [Related]  

  • 3. Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer.
    Riviere J; Bernhard JC; Robert G; Wallerand H; Deti E; Maurice-Tison S; Ardiet JM; Maire JP; Richaud P; Ferriere JM; Ballanger P; Gelet A; Pasticier G
    Eur Urol; 2010 Oct; 58(4):567-73. PubMed ID: 20598436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
    Sumitomo M; Asakuma J; Sato A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Nov; 17(11):924-30. PubMed ID: 20969640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
    Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
    Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High intensity focused pulsed ultrasound (HIFU) for local ablation of prostate carcinoma].
    Thüroff S; Chaussy C
    Urologe A; 2007 Sep; 46(9):1092. PubMed ID: 17593339
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.
    Crouzet S; Rebillard X; Chevallier D; Rischmann P; Pasticier G; Garcia G; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2010 Oct; 58(4):559-66. PubMed ID: 20619958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
    Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
    Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of localized prostate cancer using high-intensity focused ultrasound.
    Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
    BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity focused ultrasound: a potential salvage treatment for recurrent prostate cancer following radiotherapy.
    Acher PL; Thwaini A; Shergill IS; Barua JM
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):969-70. PubMed ID: 16831068
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience.
    Mearini L; D'Urso L; Collura D; Zucchi A; Costantini E; Formiconi A; Bini V; Muto G; Porena M
    J Urol; 2009 Jan; 181(1):105-11; discussion 111-2. PubMed ID: 19081465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
    Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
    Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy.
    Shoji S; Uchida T; Nakamoto M; Kim H; de Castro Abreu AL; Leslie S; Sato Y; Gill IS; Ukimura O
    J Urol; 2013 Oct; 190(4):1224-32. PubMed ID: 23583532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
    Hayashi M; Shinmei S; Asano K
    Int J Urol; 2007 Nov; 14(11):1048-50. PubMed ID: 17956536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.